The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
RB and cell cycle progression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 1×
“In cells lacking pRB, there is no association of me-K9-H3 in these promoters (Rea et al., 2000); in particular, these results have been developed by studying cyclin E, one of the best E2F target genes modulated by pRb.”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“Senescent cells, for example, show a higher level of H3K9 methylation in E2F-responsive promoters in comparison to quiescent cells (Narita et al., 2003).”
BackgroundCyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
Nuclear targeting sequences — a consensus?
Dingwall, C., & Laskey, R. A. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90184-w · Cited by 1,876
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669-1679.1994 · Cited by 965
Rb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 960
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., & Harel-Bellan, A. (1998) · Nature · doi:10.1038/35410 · Cited by 909
Rb targets histone H3 methylation and HP1 to promoters
Nielsen, S. J., Schneider, R., Bauer, U.-M., Bannister, A. J., Morrison, A., O'Carroll, D., Firestein, R., Cleary, M., Jenuwein, T., Herrera, R. E., et al. (2001) · Nature · doi:10.1038/35087620 · Cited by 904
Physical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
Zhang, H. S., Gavin, M., Dahiya, A., Postigo, A. A., Ma, D., Luo, R. X., Harbour, J. W., & Dean, D. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80625-x · Cited by 658
The E2F1–3 transcription factors are essential for cellular proliferation
Wu, L., Timmers, C., Maiti, B., Saavedra, H. I., Sang, L., Chong, G. T., Nuckolls, F., Giangrande, P., Wright, F. A., Field, S. J., et al. (2001) · Nature · doi:10.1038/35106593 · Cited by 625
Pocket proteins and cell cycle control
Cobrinik, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208619 · Cited by 601
Shirodkar, S., Ewen, M., DeCaprio, J. A., Morgan, J., Livingston, D. M., & Chittenden, T. (1992) · Cell · doi:10.1016/0092-8674(92)90214-w · Cited by 557
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7
Lee, J.-O., Russo, A. A., & Pavletich, N. P. (1998) · Nature · doi:10.1038/36038 · Cited by 459
A revised picture of the E2F transcriptional network and RB function
Stevaux, O., & Dyson, N. J. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00388-5 · Cited by 428
Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A
Mudryj, M., Devoto, S. H., Hiebert, S. W., Hunter, T., Pines, J., & Nevins, J. R. (1991) · Cell · doi:10.1016/0092-8674(91)90019-u · Cited by 356
Targeted disruption of p107: functional overlap between p107 and Rb.
Lee, M. H., Williams, B. O., Mulligan, G., Mukai, S., Bronson, R. T., Dyson, N., Harlow, E., & Jacks, T. (1996) · Genes & Development · doi:10.1101/gad.10.13.1621 · Cited by 336
Cell cycle-specific association of E2F with the p130 E1A-binding protein.
Cobrinik, D., Whyte, P., Peeper, D. S., Jacks, T., & Weinberg, R. A. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2392 · Cited by 335
Herrera, R. E., Sah, V. P., Williams, B. O., Mäkelä, T. P., Weinberg, R. A., & Jacks, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2402 · Cited by 304
E2F4 and E2F5 Play an Essential Role in Pocket Protein–Mediated G1 Control
Gaubatz, S., Lindeman, G. J., Ishida, S., Jakoi, L., Nevins, J. R., Livingston, D. M., & Rempel, R. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00071-x · Cited by 300
Rayman, J. B., Takahashi, Y., Indjeian, V. B., Dannenberg, J.-H., Catchpole, S., Watson, R. J., te Riele, H., & Dynlacht, B. D. (2002) · Genes & Development · doi:10.1101/gad.969202 · Cited by 288
Control of the cell cycle and apoptosis
Weinberg, R. A., & Lundberg, A. S. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00046-5 · Cited by 285
Chen, D., Livne-bar, I., Vanderluit, J. L., Slack, R. S., Agochiya, M., & Bremner, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.025 · Cited by 281
Molecular abnormalities in lung cancer.
Salgia, R., & Skarin, A. T. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1207 · Cited by 276
E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes
Di Stefano, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg613 · Cited by 274
Identification of Germline and Somatic Mutations Affecting the Retinoblastoma Gene
Dunn, J. M., Phillips, R. A., Becker, A. J., & Gallie, B. L. (1988) · Science · doi:10.1126/science.3175621 · Cited by 265
Tedesco, D., Lukas, J., & Reed, S. I. (2002) · Genes & Development · doi:10.1101/gad.1011202 · Cited by 261
Specific enzymatic dephosphorylation of the retinoblastoma protein.
Ludlow, J. W., Glendening, C. L., Livingston, D. M., & DeCarprio, J. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.367 · Cited by 258
Jackman, M., Firth, M., & Pines, J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07153.x · Cited by 256
Strober, B. E., Dunaief, J. L., Guha, S., & Goff, S. P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1576 · Cited by 253
[Molecular abnormalities in lung cancer].
Shimizu, S., & Mitsudomi, T. (2002) · PubMed · Cited by 235
Role of E2F in cell cycle control and cancer
Johnson, D. G. (1998) · Frontiers in Bioscience · doi:10.2741/a291 · Cited by 224
Retinoblastoma protein family in cell cycle and cancer: A review
Paggi, M. G., Baldi, A., Bonetto, F., & Giordano, A. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199609)62:3<418::aid-jcb12>3.0.co;2-e · Cited by 221
Self-citationVandel, L., Nicolas, E., Vaute, O., Ferreira, R., Ait-Si-Ali, S., & Trouche, D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6484-6494.2001 · Cited by 217
Linking the Rb and Polycomb Pathways
Dahiya, A., Wong, S., Gonzalo, S., Gavin, M., & Dean, D. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00346-x · Cited by 195
Lai, A., Lee, J. M., Yang, W.-M., DeCaprio, J. A., Kaelin, W. G., Seto, E., & Branton, P. E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6632 · Cited by 168
Qian, Y., Luckey, C., Horton, L., Esser, M., & Templeton, D. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5363 · Cited by 165
Lees, E. M., & Harlow, E. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.1194 · Cited by 159
Transcriptional control by E2F
Adams, P. D., & Kaelin, W. G. (1995) · Seminars in Cancer Biology · doi:10.1006/scbi.1995.0013 · Cited by 143
E2F4 loss suppresses tumorigenesis in Rb mutant mice
Lee, E. Y., Cam, H., Ziebold, U., Rayman, J. B., Lees, J. A., & Dynlacht, B. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00207-6 · Cited by 138
Jeanblanc, M., Mousli, M., Hopfner, R., Bathami, K., Martinet, N., Abbady, A. Q., Siffert, J.-C., Mathieu, É., Muller, C. D., & Bronner, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208878 · Cited by 134
Mechanism of Transcriptional Repression of E2F by the Retinoblastoma Tumor Suppressor Protein
Ross, J. F., Liu, X., & Dynlacht, B. D. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80310-x · Cited by 126
New roles for the RB tumor suppressor protein
Liu, H., Dibling, B. C., Spike, B. T., Dirlam, A., & Macleod, K. F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.005 · Cited by 122
An E2F-like repressor of transcription
Morkel, M., Wenkel, J., Bannister, A. J., Kouzarides, T., & Hagemeier, C. (1997) · Nature · doi:10.1038/37507 · Cited by 120
BRG1 Controls the Activity of the Retinoblastoma Protein via Regulation of p21CIP1/WAF1/SDI
Kang, H., Cui, K., & Zhao, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1188-1199.2004 · Cited by 116
Aberrant Cell Cycle Regulation in Cervical Carcinoma
Kim, Y. T., & Zhao, M. (2005) · Yonsei Medical Journal · doi:10.3349/ymj.2005.46.5.597 · Cited by 114
Cyclin D1 production in cycling cells depends on Ras in a cell-cycle-specific manner
Hitomi, M., & Stacey, D. W. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80476-x · Cited by 112
The molecular basis of cell cycle and growth control
Stein, G. S. (1999) · Cited by 95
Modulation of Cell Cycle Components by Epigenetic and Genetic Events
Macaluso, M., Montanari, M., Cinti, C., & Giordano, A. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.009 · Cited by 94
Self-citationMultiple Changes in E2F Function and Regulation Occur upon Muscle Differentiation
Shin, E. K., Shin, A., Paulding, C., Schaffhausen, B. S., & Yee, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.2252 · Cited by 92
A Unique Domain of pRb2/p130 Acts as an Inhibitor of Cdk2 Kinase Activity
Luca, A. D., MacLachlan, T. K., Bagella, L., Dean, C., Howard, C. M., Claudio, P. P., Baldi, A., Khalili, K., & Giordano, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20971 · Cited by 90
Self-citationThe retinoblastoma family: twins or distant cousins?
Claudio, P. P., Tonini, T., & Giordano, A. (2002) · Genome biology · doi:10.1186/gb-2002-3-9-reviews3012 · Cited by 87
Self-citationCinti, C., Leoncini, L., Nyong'o, A. O., Ferrari, F., Lazzi, S., Bellan, C., Vatti, R., Zamparelli, A., Cevenini, G., osi, G. M. T., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64941-3 · Cited by 77
Self-citationExpression of cyclins E1 and E2 during mouse development and in neoplasia
Geng, Y., Yu, Q., Whoriskey, W., Dick, F. A., Tsai, K. Y., Ford, H. L., Biswas, D. K., Pardee, A. B., Amati, B. B., Jacks, T., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231487798 · Cited by 74
de la Luna, S., Burden, M. J., Lee, C., & Thangue, N. B. L. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.10.2443 · Cited by 73
Inhibition of oncogenic transformation by mammalian Lin‐9, a pRB‐associated protein
Gagrica, S., Hauser, S., Kolfschoten, I., Osterloh, L., Agami, R., & Gaubatz, S. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600470 · Cited by 65
Distinct Mechanisms for Regulating the Tumor Suppressor and Antiapoptotic Functions of Rb
Ma, D., Zhou, P., & Harbour, J. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301761200 · Cited by 64
Lazzi, S., Bellan, C., Falco, G. D., Cinti, C., Ferrari, F., Nyong'o, A. O., Claudio, P. P., Tosi, G. M., Vatti, R., Gloghini, A., et al. (2002) · Human Pathology · doi:10.1053/hupa.2002.125372 · Cited by 59
Self-citationCyclin C Makes an Entry into the Cell Cycle
Sage, J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00137-6 · Cited by 52
Genomic structure of the human retinoblastoma-related Rb2/p130 gene.
Baldi, A., Boccia, V., Claudio, P. P., Luca, A. D., & Giordano, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4629 · Cited by 50
Self-citationRole of cell‐cycle regulators in lung cancer
Caputi, M., Russo, G. M., Esposito, V., Mancini, A., & Giordano, A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20424 · Cited by 36
Self-citationDifferential regulation of apoptotic genes by Rb in human versus mouse cells
Young, A. P., & Longmore, G. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207330 · Cited by 30
Ichimura, K., Hanafusa, H., Takimoto, H., Ohgama, Y., Akagi, T., & Shimizu, K. (2000) · Gene · doi:10.1016/s0378-1119(00)00193-1 · Cited by 25
Chappel, J. C., Ross, F. P., Abu‐Amer, Y., Shaw, A. S., & Teitelbaum, S. L. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19971215)67:4<423::aid-jcb1>3.0.co;2-u · Cited by 22
Regulation of PML-dependent transcriptional repression by pRB and low penetrance pRB mutants
Fang, W., Mori, T., & Cobrinik, D. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205666 · Cited by 22
Genetic Dissection of Centromere Function
Schulman, I. G., & Bloom, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3156-3166.1993 · Cited by 16
Are RB proteins a potential substrate of Pin1 in the regulation of the cell cycle?
Gallo, G., & Giordano, A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20451 · Cited by 13
Self-citationThe retinoblastoma gene family: its role in cancer onset and progression
Cinti, C., & Giordano, A. (2000) · Emerging Therapeutic Targets · doi:10.1517/14728222.4.6.765 · Cited by 11
Self-citation
Cited by
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
Role of interleukin-6 in cancer progression and therapeutic resistance
Kumari, N., Dwarakanath, B. S., Das, A., & Bhatt, A. N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5098-7 · Cited by 1,092
Dechat, T., Pfleghaar, K., Sengupta, K., Shimi, T., Shumaker, D. K., Solimando, L., & Goldman, R. D. (2008) · Genes & Development · doi:10.1101/gad.1652708 · Cited by 940
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
Self-citationLiu, Y., Cao, Y., Zhang, W., Bergmeier, S., Qian, Y., Akbar, H., Colvin, R., Ding, J., Tong, L., Wu, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0131 · Cited by 555
Metadata
- Authors
- Giacinti, C., & Giordano, A.
- Venue
- Oncogene
- Published
- 2006-08-28
- Volume
- 25
- Issue
- 38
- Pages
- 5220-5227
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1982166284
- Cited by
- 1,216
- References
- 75
- FWCI
- 22.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.